中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

慢性丙型肝炎并发甲状腺功能亢进导致肝衰竭1例报告

王慰 卢伟娜 姚春甫 邵石祥 高恒波

引用本文:
Citation:

慢性丙型肝炎并发甲状腺功能亢进导致肝衰竭1例报告

DOI: 10.3969/j.issn.1001-5256.2016.08.032
基金项目: 

河北省医学科学研究重点课题计划(20150156); 

详细信息
  • 中图分类号: R512.63;R581.1;R575.3

Liver failure due to chronic hepatitis C with hyperthyroidism: a case report

Research funding: 

 

  • 摘要: <正>1病例资料患者女性,50岁,因"抗-HCV阳性11个月,尿黄7 d"于2015年6月3日入院。既往23年前行"剖宫产"手术,有输血史。患者2014年7月体检发现抗-HCV阳性,HCV RNA 5.2×106IU/ml,肝功能正常,甲状腺功能四项示促甲状腺激素(thyroid stimulating hormone,TSH)稍低,余正常。给予聚乙二醇干扰素(PEG-IFN)α-2b 80μg/周联合利巴韦林900 mg/d抗

     

  • [1] FRIEDRICH-RUST M,THEOBALD J,ZEUZEM S,et al.Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic Hepatitis C[J].Viral Hepatol,2009,16(3):168-177.
    [2] VEZALI E,ELEFSINIOTIS L,MIHAS C,et al.Thyroid dysfunction in patients with chronic hepatitis C:virus-or therapy-related?[J].J Gastroenterol Hepatol,2009,24(6):1024-1029.
    [3] VASILIADIS T,ANAGNOSTIS P,NALMPANTIDIS G,et al.Thyroid dysfunction and long-term outcome during and after interferon-alpha therapy in patients with chronic hepatitis C[J].Ann Acad Med Singapore,2011,40(9):394-400.
    [4]MENCONI F,HASHAM A,TOMER Y.Environmental triggers of thyroiditis:hepatitis C and interferon-α[J].J Endocrinol Invest,2011,34(1):78-84.
    [5]ZHOU M,SUO YJ.A comparative study on standardized131I therapy in patients with Grave’s hyperthyroidism at different age ranges[J].J Clin Exp Med,2015,14(21):1798-1801.(in Chinese)周敏,索艳君.标准化131I治疗不同年龄段Grave’s甲亢的对比研究[J].临床和实验医学杂志,2015,14(21):1798-1801.
    [6]HU B,SHI LH,TANG CB,et al.Study on the pathogen of postcholecystectomy syndrome non-induction by comcretion and tumor and the measurement of prevention and cure[J].N Chin Coal Med Coll,2005,7(1):11-12.(in Chinese)胡兵,石丽红,唐采白,等.非结石及肿瘤因素胆囊切除术后综合征的病因及防治[J].华北煤炭医学院学报,2005,7(1):11-12.
    [7]JIANG NY,KUANG AR,TAN J,et al.Interpretation of experts consensus on131I therapy of Graves’s hyperthyroidism(2010)[J].Chin J Nucl Med,2010,30(5):346-351.(in Chinese)蒋宁一,匡安仁,谭建,等.131I治疗Graves甲亢专家共识(2010年)[J].中华核医学杂志,2010,30(5):346-351.
    [8] TRAN HA,ATTIA JR,JONES TL,et al.Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C under going combination therapy:a nested case control study[J].BMC Endocr Disord,2011,11(1):10.
  • 加载中
计量
  • 文章访问数:  1457
  • HTML全文浏览量:  15
  • PDF下载量:  407
  • 被引次数: 0
出版历程
  • 出版日期:  2016-08-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回